Symptomatology and general principle of treatment of acute glomerulonephritis

Acute Glomerulonephritis (AGN) represents a complex cluster of renal diseases characterized by the sudden onset of hematuria, proteinuria, and red blood cell casts, often accompanied by hypertension and edema. While the clinical presentation is well-documented, the heterogeneity of symptomatology and the variance in response to standard treatment protocols pose significant challenges for precision medicine. Traditional diagnostic categories often fail to capture the temporal dynamics of the disease, leading to delayed or suboptimal therapeutic interventions. This paper proposes a novel framework for analyzing AGN symptomatology through advanced computational phenotyping and data-driven modeling. Drawing upon methodologies recently applied in neurodegenerative and psychiatric disorders, we argue that the integration of computable phenotypes and machine learning can refine the classification of AGN. We discuss the potential for identifying distinct symptomatic sub-groups and tailoring general principles of treatment—such as fluid management and immunosuppression—based on objective, quantitative biomarkers rather than subjective clinical observation alone.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-03-03
DOI
https://doi.org/10.5281/zenodo.18843862
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Symptomatology and general principle of treatment of acute glomerulonephritis

Swetha Ganesan
Zenodo (CERN European Organization for Nuclear Research)
Chronic Kidney Disease and Diabetes
article

Symptomatology and general principle of treatment of acute glomerulonephritis

Swetha Ganesan
article en

Abstract

Acute Glomerulonephritis (AGN) represents a complex cluster of renal diseases characterized by the sudden onset of hematuria, proteinuria, and red blood cell casts, often accompanied by hypertension and edema. While the clinical presentation is well-documented, the heterogeneity of symptomatology and the variance in response to standard treatment protocols pose significant challenges for precision medicine. Traditional diagnostic categories often fail to capture the temporal dynamics of the disease, leading to delayed or suboptimal therapeutic interventions. This paper proposes a novel framework for analyzing AGN symptomatology through advanced computational phenotyping and data-driven modeling. Drawing upon methodologies recently applied in neurodegenerative and psychiatric disorders, we argue that the integration of computable phenotypes and machine learning can refine the classification of AGN. We discuss the potential for identifying distinct symptomatic sub-groups and tailoring general principles of treatment—such as fluid management and immunosuppression—based on objective, quantitative biomarkers rather than subjective clinical observation alone.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 43%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Symptomatology and general principle of treatment of acute glomerulonephritis — Swetha Ganesan · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS